Genelux Corp (GNLX) — 8-K Filings

8-K Filings (13)

• Genelux Corp Files 8-K: Board Changes & Shareholder Votes — Sep 3, 2025 Risk: medium
  On August 27, 2025, Genelux Corporation announced changes in its board of directors and executive compensation. The company also reported on matters submitted t
• 8-K Filing — Mar 25, 2025
• Genelux Corp Files 8-K: Board & Officer Changes — Feb 3, 2025 Risk: low
  On January 29, 2025, Genelux Corporation filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensat
• 8-K Filing — Nov 8, 2024
• Genelux Adds Biotech Veteran Sidransky to Board — Oct 3, 2024 Risk: low
  On September 23, 2024, Genelux Corporation announced the election of Dr. David L. Sidransky to its Board of Directors, effective immediately. Dr. Sidransky brin
• Genelux Corp Files 8-K on Security Holder Vote Matters — Aug 6, 2024 Risk: low
  On August 1, 2024, Genelux Corporation filed an 8-K report indicating a submission of matters to a vote of security holders. The filing details the company's co
• Genelux Corp Files 8-K Report — Aug 1, 2024 Risk: low
  On August 1, 2024, Genelux Corporation filed an 8-K report to disclose information under Regulation FD and to file financial statements and exhibits. The compan
• 8-K Filing — Jun 5, 2024
• Genelux Corp Files 8-K with Material Agreement — May 24, 2024 Risk: medium
  On May 23, 2024, Genelux Corporation entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also
• Genelux Corp Files 8-K: Regulation FD & Exhibits — Apr 9, 2024 Risk: low
  On April 9, 2024, Genelux Corporation filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spec
• Genelux Corp Files 8-K Report — Apr 2, 2024 Risk: low
  On April 1, 2024, Genelux Corporation filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spec
• Genelux Files Routine 8-K, Confirms Nasdaq Listing — Feb 5, 2024
  Genelux Corporation filed an 8-K on February 5, 2024, primarily to disclose general corporate information and confirm its status as a publicly traded company on
• Genelux Files Routine 8-K on Operations & Other Events — Feb 2, 2024
  Genelux Corporation filed an 8-K on February 2, 2024, indicating a routine filing for 'Results of Operations and Financial Condition' and 'Other Events'. This f

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX